IOMED will showcase a presentation on "Empowering Clinical Research with AI: Unlocking the Value of RWD"

IOMED’s CEO, Rohit Mistry, will talk about unlocking the value of Real-World Data, and how Artificial Intelligence improves clinical research, enabling the acceleration of patient recruitment processes and the reduction of research timelines at Global Clinical Trials Connect, which will take place on May 28 and 29 at the Hilton London Kensington (United Kingdom).

IOMED will participate in the Global Clinical Trials Connect with a presentation on how to enhance clinical research using Artificial Intelligence by unlocking the value of real-world data, as well as sponsoring the event, which will take place on May 28 and 29 at the Hilton London Kensington (United Kingdom). The seventh edition of the Global Clinical Trials Connect will provide a platform for discussions about futuristic advancements in clinical trials and clinical research. Pharmaceutical and biotechnology companies are constantly evolving, and new clinical studies, technologies, and advancements in care and treatments have increased the efficacy and, at the same time, the complexity of clinical trials, which are carried out in a highly structured and closely coordinated manner.

Rohit Mistry, CEO of IOMED, will deliver the presentation "Empowering Clinical Research with Artificial Intelligence: Unlocking the Value of Real-World Data" on Wednesday, May 29, at 11:20 AM.

"Real-world data plays a fundamental role in driving substantial advances in clinical research and fostering the development of innovative treatments," he states.